{"name":"American Regent, Inc.","slug":"american-regent-inc","ticker":"","exchange":"","domain":"americanregent.com","description":"","hq":"Shirley","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"Ferrous Sulfate tablets","genericName":"Ferrous Sulfate tablets","slug":"ferrous-sulfate-tablets","indication":"Other","status":"marketed"},{"name":"Taxoprexin","genericName":"Taxoprexin","slug":"taxoprexin","indication":"Other","status":"discontinued"},{"name":"Cohort III","genericName":"Cohort III","slug":"cohort-iii","indication":"Other","status":"phase_2"},{"name":"Standard Medical Care (SMC)","genericName":"Standard Medical Care (SMC)","slug":"standard-medical-care-smc","indication":"General medical care","status":"phase_3"},{"name":"Tralement","genericName":"Tralement","slug":"tralement","indication":"Other","status":"marketed"},{"name":"VIT-45","genericName":"VIT-45","slug":"vit-45","indication":"Secondary hyperparathyroidism in patients with chronic kidney disease","status":"phase_3"},{"name":"Venofer® 200 mg","genericName":"Venofer® 200 mg","slug":"venofer-200-mg","indication":"Other","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"cardiovascular","drugs":[{"name":"Iron Sucrose (Venofer)","genericName":"Iron Sucrose (Venofer)","slug":"iron-sucrose-venofer","indication":"Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","status":"marketed"},{"name":"Iron Sucrose + Erythropoietin","genericName":"Iron Sucrose + Erythropoietin","slug":"iron-sucrose-erythropoietin","indication":"Anemia in patients with chronic kidney disease on dialysis","status":"phase_3"},{"name":"Oral Iron + Erythropoietin","genericName":"Oral Iron + Erythropoietin","slug":"oral-iron-erythropoietin","indication":"Anemia of chronic kidney disease","status":"phase_3"},{"name":"iron sucrose injection USP","genericName":"iron sucrose injection USP","slug":"iron-sucrose-injection-usp","indication":"Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","status":"phase_3"},{"name":"stable erythropoietin therapy","genericName":"stable erythropoietin therapy","slug":"stable-erythropoietin-therapy","indication":"Anemia associated with chronic kidney disease","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ferric Carboxymaltose (FCM)","genericName":"Ferric Carboxymaltose (FCM)","slug":"ferric-carboxymaltose-fcm","indication":"Iron deficiency anemia in patients with chronic kidney disease (CKD), including those on hemodialysis and non-dialysis dependent patients","status":"marketed"}]}],"pipeline":[{"name":"Ferrous Sulfate tablets","genericName":"Ferrous Sulfate tablets","slug":"ferrous-sulfate-tablets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Taxoprexin","genericName":"Taxoprexin","slug":"taxoprexin","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cohort III","genericName":"Cohort III","slug":"cohort-iii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ferric Carboxymaltose (FCM)","genericName":"Ferric Carboxymaltose (FCM)","slug":"ferric-carboxymaltose-fcm","phase":"marketed","mechanism":"Ferric carboxymaltose delivers iron directly into the bloodstream as a stable iron-carbohydrate complex that is taken up by iron-binding proteins to replenish depleted iron stores.","indications":["Iron deficiency anemia in patients with chronic kidney disease (CKD), including those on hemodialysis and non-dialysis dependent patients","Iron deficiency anemia in patients with heart failure","Iron deficiency anemia in non-dialysis dependent CKD patients"],"catalyst":""},{"name":"Iron Sucrose (Venofer)","genericName":"Iron Sucrose (Venofer)","slug":"iron-sucrose-venofer","phase":"marketed","mechanism":"Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and treat iron deficiency anemia.","indications":["Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","Iron deficiency anemia in patients with chronic kidney disease not on dialysis","Iron deficiency anemia in patients receiving erythropoiesis-stimulating agents"],"catalyst":""},{"name":"Iron Sucrose + Erythropoietin","genericName":"Iron Sucrose + Erythropoietin","slug":"iron-sucrose-erythropoietin","phase":"phase_3","mechanism":"Iron sucrose replenishes iron stores while erythropoietin stimulates red blood cell production to treat anemia in patients with chronic kidney disease.","indications":["Anemia in patients with chronic kidney disease on dialysis","Iron deficiency anemia in chronic kidney disease patients"],"catalyst":""},{"name":"Oral Iron + Erythropoietin","genericName":"Oral Iron + Erythropoietin","slug":"oral-iron-erythropoietin","phase":"phase_3","mechanism":"This combination therapy replaces iron stores to support hemoglobin synthesis while erythropoietin stimulates red blood cell production to treat anemia.","indications":["Anemia of chronic kidney disease","Chemotherapy-induced anemia","Iron deficiency anemia"],"catalyst":""},{"name":"Standard Medical Care (SMC)","genericName":"Standard Medical Care (SMC)","slug":"standard-medical-care-smc","phase":"phase_3","mechanism":"Standard Medical Care (SMC) is a treatment that does not involve a specific mechanism of action.","indications":["General medical care"],"catalyst":""},{"name":"Tralement","genericName":"Tralement","slug":"tralement","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"VIT-45","genericName":"VIT-45","slug":"vit-45","phase":"phase_3","mechanism":"VIT-45 is a vitamin D analog that enhances immune function and reduces inflammation through vitamin D receptor signaling.","indications":["Secondary hyperparathyroidism in patients with chronic kidney disease"],"catalyst":""},{"name":"Venofer® 200 mg","genericName":"Venofer® 200 mg","slug":"venofer-200-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"iron sucrose injection USP","genericName":"iron sucrose injection USP","slug":"iron-sucrose-injection-usp","phase":"phase_3","mechanism":"Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and support hemoglobin synthesis in patients with iron deficiency.","indications":["Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","Iron deficiency anemia in patients with chronic kidney disease not on dialysis","Iron deficiency anemia in patients receiving erythropoiesis-stimulating agents"],"catalyst":""},{"name":"stable erythropoietin therapy","genericName":"stable erythropoietin therapy","slug":"stable-erythropoietin-therapy","phase":"phase_3","mechanism":"Stable erythropoietin therapy works by stimulating the production of red blood cells.","indications":["Anemia associated with chronic kidney disease","Anemia associated with chemotherapy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRmhsaFVPVl9rUEtQTGNIX1hDSU9Db3NEV21ad1lkc3FvUDV6bXlBbnhhbnFmS2hqS3dyMllub0s5czlqb1ZzYm1jOEJFOWo4U0hkRGxqQVhaSm5rRGk4akQxaVVrVklweDVHMENoelVpNGdqVDlualdPWTA5ZWx4Qzh5ZmJDcHk4VHJYNkZXMzAwOV9iQUR1Rk1GSVRxNEtCTHpsTll4SGMyRE5jTmR2N01HODJOVzZ5VHZCOXJKWkFuOU9DdDc5Q0o2NFVXS01fc2wzQmU2LWlLNHRXbVdjdXJ5V25VaHQ5Uy1FMXhiRkcwXzF3WFhQTkFHR1BwWjg?oc=5","date":"2026-04-01","type":"pipeline","source":"GlobeNewswire","summary":"Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030 - GlobeNewswire","headline":"Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPTG9kb09aazZnMWczSXNCZGJvRnpUamtROHI1ZngwWFloWDVvRTNYQ2FOdFJaSTBRZENhMTlxcHRCV0FBZ3NnUFVCQmM4Qzl3S2k1OXZWb1lwQ2NYbVNCU0tQQTR4UWQxODVtbW5TdEtaeEVmQTJVZTJ5b0c2U2xqQ3JjdUo3eG1oOFIwbw?oc=5","date":"2025-11-24","type":"deal","source":"Yahoo Finance","summary":"Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million - Yahoo Finance","headline":"Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal he","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOX1BGYVhvVWlxMjk2enNrbnBmZkdwdXBRdS1vQnRhLUZxQUJvcU9lZkFvMkNhVjdtRWNhWEhoajBieUdkOWVVajJ6THlRODlyM3MzY2FDQVNac005Z0NwQ1N1Y0FYbkVvQWl2eHJxZXVtdlA1OFZZSGk4Tm9ubV9RdnNKZmQyMVVpaktUZkNnTGR6NUluTDVpMnI1akhNRTJuZ1RRLXo2UWJsbDA?oc=5","date":"2025-09-12","type":"pipeline","source":"The Business Journals","summary":"Central Ohio biotech industry plans $30M job-training center after losing major project to NC - The Business Journals","headline":"Central Ohio biotech industry plans $30M job-training center after losing major project to NC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNQVVmSjNHbFBlb3dLcGZYVk93NEhLbDRkaGNyVUtpQzhRQzJFNlVxTHlVdDhkTXppTEJlSUMzZFU1VzBQWXEzVXZoWTNEZmdSZGRxaUZrOUtfTUhZbEtaWUExVTIwR216YUtJczJneHFYYlNoQ0JfU25Hdk9yZUhuMk12SFEwSmhlNV8xRXpRTXNBM2lkZ3hTLVAzYmVzS2luRGxZQi1BZC1iX21hcVdJTDRB?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"American Regent® Launches Gvoke VialDx™ (glucagon injection) - PR Newswire","headline":"American Regent® Launches Gvoke VialDx™ (glucagon injection)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQczNWRUxJMG1mTXItU2tvNVdxWjktRkhpR1pWR3RKYTI4TTYzZFI0WVJ3QUs3ZVQxdGU2aFhWeW4xU2F3ZFNFVmFpWW9lLUpfTTFYQkFGMGpCRm42TEw5b0FwUi1aSzRpSEhYNmQxMVphVW9NcWp5MDFvOG1pVEVLZm5YcW1MVngtc2VFX0U1SDMtRkVYT016Yk45TdIBVkFVX3lxTE83b0Nqa3lNWDFUN0VsY3FfbUVfQnY4UlNGbWwxbjdlejByN0paWDAxcE5ZclI0M2x0dXJoTjU5OUhXU3BRSEtSVWZ5ckdBUDZPM2JlQXN3?oc=5","date":"2025-07-15","type":"patent","source":"Law360","summary":"Court Blocks Generic Selenium Products Amid Patent Suit - Law360","headline":"Court Blocks Generic Selenium Products Amid Patent Suit - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOYU1tY2tfOV9BQ19LdHpuRTUzM0Q2OFJaTk1iOFp3U0l6cEY4eDBjSk5Mdng0bG1kcEdpR1JpT1duOTBBZ1k1RUExS0EtUUtGM1hZM2JuRThMRXBzNjMweVRDZnM1NndqVFJ6OGVaUjNqdDNnWV93WTVxY3phQ2ZoOEtn?oc=5","date":"2024-05-29","type":"pipeline","source":"Long Island Business News","summary":"Pharmaceutical maker expands with Shirley lease - Long Island Business News","headline":"Pharmaceutical maker expands with Shirley lease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPVVVyMFM2SW9SVkdhSTlBSmJTRVhsTHl5UGM2TnBSLVlsYlltOVJnbmoweVktLV9Md3d1SWM4eDRKYWFYQ0I3SlRIbWdpUmduMnVYSVplaWpVbUowMVY4YzExMUtnQWVCQUh3b0pLc0hRRUVWYWFOc3ZBYWdzbnJQaHpRZmxRaWJTcWFSSExUTkxPOV9yRlRuSXd4WVZMbHlUTGlMMUlFeGxLcEhsTE9KalUyYlg?oc=5","date":"2023-06-07","type":"regulatory","source":"dicardiology.com","summary":"Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure - dicardiology.com","headline":"Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNbW9uWnNlbC1RS0ZkSkdOUktVQi1RM3A0YkF2cnR4cnNVcjF0c0cybGtRMy1FRUREMnR0UzgxSzdYYVhpak93Ym5JTk5IVF9XYWhuRFFOZ1lWc0EzVmtLOFlhd083a0lDN3k4enphU3ppREZIMkR5MHNIeEUzUzBMUXZMNUlNZw?oc=5","date":"2022-08-18","type":"deal","source":"Contract Pharma","summary":"American Regent Acquires HBT Labs - Contract Pharma","headline":"American Regent Acquires HBT Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFF6V1Z1b0xCZkpDaTdFS3RCelJEc0hPWUFzeDgxZjBlcU84b3BLVURYUms4RXVkR3JTSkFPbVdaREpRX09MWGl1eWVjTnNJOTBLanhfZ0M4aXlWX3ZfV1BiRDRCdnZNbkkzcm80TEJlaFM4ZXlUbkNYanJObXpqX1hRNmk2RDFfckhYYklkQVpaRWRSZHlqWnZXOFI?oc=5","date":"2022-08-17","type":"pipeline","source":"PR Newswire","summary":"HBT Labs, Inc. to Join American Regent, Inc. - PR Newswire","headline":"HBT Labs, Inc. to Join American Regent, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPREllWm5qMUYzU0tUcnpPUUxONlAyU3hpV21Gb3hvTEx1bkJoSURtb2l6amh3OG9fU2laTUZvc2FCVmF4WUp1Y19DLXVZVVpqR0V0MC1pY3Z0QjdvLTE2aF9qUDRoVlRUeURSY2M0WUlHSW41SjB0XzBOS1ZFWU5DVlByamZ6T3lNcFdUV3owaXJ4Q29kM0RlT0F2aW1zT0hnRERjM0V1Yjl2NHRuLVE?oc=5","date":"2020-11-12","type":"pipeline","source":"PR Newswire","summary":"American Regent, Inc. Announces CEO Transition for 2021 - PR Newswire","headline":"American Regent, Inc. Announces CEO Transition for 2021","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQUVlfMF95Vllfa3IxNHBtWEs1bjAtWnFRQ0pVSU05Tzk5aUVtRU5fMERha1p6ZVVETll4Ui1tRnJfOXYtX2dZbkkydzJtdW1pTWZGRFFXb3E5bGVKbUJhZ0ttbEh6OEFwN3gyUDJNU0Nmd0hRMlFlTHkwd1owLVdPTWVWTFhna1pITU0ydkFWNA?oc=5","date":"2020-06-02","type":"pipeline","source":"US Equestrian","summary":"American Regent Animal Health Continues with Commitment to Horse Sport Through Support of US Equestrian - US Equestrian","headline":"American Regent Animal Health Continues with Commitment to Horse Sport Through Support of US Equestrian","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNUGg1elRZbXBubnd6ZW1tSlpMSFBlR1lJaEJTQzkyZDNvd0lCYzZCSGhEWEhTamlkajFsLUZ6TV90OHQyeDF0TEVOUGdmbUdMMnhLdTVDZWs2c2hobTFkODJWWkRqd2xOQ0xNbWRCU21fYW9FbU5XZHhvWlFSYnpxY016cjZLYTlJUE1xVllGaWhETUZCek9BMVJ2MGVrSnVfQU5LZFcwcmpxM1Z2WFpPNUZB?oc=5","date":"2019-01-02","type":"pipeline","source":"PR Newswire","summary":"Luitpold Pharmaceuticals, Inc. Renamed American Regent, Inc. - PR Newswire","headline":"Luitpold Pharmaceuticals, Inc. Renamed American Regent, Inc.","sentiment":"neutral"}],"patents":[],"drugCount":13,"phaseCounts":{"marketed":5,"discontinued":1,"phase_2":1,"phase_3":6},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}